Barinthus Biotherapeutics plc (BRNS) Tops Q1 EPS by 18c

Barinthus Biotherapeutics plc (NASDAQ: BRNS) reported Q1 EPS of ($0.14), $0.18 better than the analyst estimate of ($0.32).

For earnings history and earnings-related data on Barinthus Biotherapeutics plc (BRNS) click here.

You May Also Be Interested In

• Reports Of Blasts Across Iran's Southern Regions: State TV - Bloomberg
• Daxor Corp. (DXR) PT Lowered to $18 at Lake Street
• Trump: Pastor Darrell Scott To Serve As Tobacco Advisor